DH Roukos - Annals of surgical oncology, 2011 - Springer Each human being and each cancer patient is unique. Based on this assessment provided by the current personal genomics revolution, the emerging conceptual design is great. By identifying the genetics, genomics, and epige- nomics variants underlying cancer phenotype, we ... Cited by 24 - Related articles - All 4 versions
MW Babyatsky… - Journal of Investigative Medicine, 2011 - journals.lww.com Dr. Babyatsky's research has focused on the role of somatostatin in Inflammatory Bowel Disease. He has earned several awards and honors for his work, including a Crohn's and Colitis Foundation of America First Award and the Solomon Silver Award from Mount Sinai ...
[HTML] from ascopubs.orgHJ Burstein, PB Mangu, MR Somerfield… - … of Clinical Oncology, 2011 - jco.ascopubs.org Methods An Update Working Group reviewed data published between December 1, 2003, and May 31, 2010. MEDLINE and the Cochrane Library were searched. The literature search yielded 11,313 new articles. The limits for “human and English” were used, and then standard ...
ME Hammond, DF Hayes… - … of Clinical Oncology, 2011 - jco.ascopubs.org We wish to call your attention to a Clinical Notice (available at www.asco.org/guidelines/her2 , www.asco.org/guidelines/erpr, and http://goo.gl/96Gnl) recently released by the American Society of Clinical Oncology (ASCO) and the College of American Pathologists (CAP) on behalf of ... Cited by 2 - Related articles - All 4 versions
HR Cardenes, AM Moore, CS Johnson… - … of Clinical Oncology, 2011 - journals.lww.com Methods: Eligible patients had biopsy-proven LAPC without evidence of metastatic disease. In part A of the treatment plan, patients received GEM 600 mg/m 2 IV weekly, with concurrent RT (50.4 Gy in 28 fractions, 1.8 Gy/d, 5 days per week). Part B of the treatment plan began ... Cited by 1 - Related articles - All 4 versions